Medable, Pluto Health Strike Enterprise Partnership
Collaboration to focus on accelerating clinical development and increase access to research.
Medable Inc. announced in a company press release that it has formed a partnership with Pluto Health, a smart care coordination services company. Combining Pluto Health’s health coordination platform and Medable’s digitally enabled clinical trials platform, the joint venture aims to providing patients with greater control and the ability to share their health data directly into clinical trials through a seamless integration.
“Our partnership is primarily a win for patients, alongside other stakeholders, who will benefit from ongoing enhanced support,” said Joy Bhosai, MD, PhD, CEO, founder, Pluto Health, in a company press release. “Pluto is passionate about improving patient care in communities and designing systems that deliver resources for patients to manage health needs over time, especially if they are going through a clinical trial as part of a care option. We are excited for what the future holds with Medable.”
Reference: Medable Partners with Pluto Health to Optimize Patient Experience and Improve Access to Clinical Trials. Business Wire. October 3, 2023. Accessed October 3, 2023. https://www.businesswire.com/news/home/20231003413736/en/Medable-Partners-with-Pluto-Health-to-Optimize-Patient-Experience-and-Improve-Access-to-Clinical-Trials
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
